|

Transversus Abdominis Plan (TAP) Block In Transcatheter Aortic Valve Implantation (TAVI)

RECRUITINGN/ASponsored by Istanbul University - Cerrahpasa
Actively Recruiting
PhaseN/A
SponsorIstanbul University - Cerrahpasa
Started2024-12-28
Est. completion2025-04-30
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

Hemodynamic stability is the main goal of the anesthetic method during TAVI. Pain during the procedure may cause patients to move therefore hemodynamic instability. This may lead to undesirable complications for the patient and the physician. At the same time, it may affect the process quality and cause the processing time to be extended. In this prospective-randomised study, ultrasound-guided transversus abdominis plan block will be performed to reduce pain. We aimed to contribute to the reduction of undesirable outcomes for the patient and physician by providing adequate anesthesia with TAP block accompanied by sedation, and to present its impact on the quality of the healthcare service provided by evaluating patient and physician satisfaction.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* TAVI procedures
* over 18 years of age
* INR \< 1,5
* elective procedures
* Signing the volunteer consent form
* Providing optimal images in ultrasound imaging

Exclusion Criteria:

* \< 18 yers of age
* emergency procedures
* morbidly obese patients (BMI\>35kg/m2)
* Advanced decompensated heart failure with New york Heart Association (NYHA) stage 4
* Those who have skin infection, lesion, hematoma in the area to be blocked
* Cannot be communicated and cannot be given a position
* Allergic to the prescribed medications
* Pregnants
* Those who refused to sign volunteer consent form

Conditions5

AnalgesiaAnesthesiaAortic Valve StenosisBlockHeart Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.